Kura Oncology Inc (KURA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs
Research and Development Expenses: $39.7 million for Q2 2024, up from $28.2 million in Q2 2023. General and Administrative Expenses: $16.7 million for Q2 2024, compared to $11.8 million in Q2 2023. Ne...